Potent and selective EGFR inhibitors based on 5-aryl-7H-pyrrolopyrimidin-4-amines
-
Add time:08/28/2019 Source:sciencedirect.com
The epidermal growth factor receptor represents an important target in cancer therapy, and low molecular weight inhibitors based on quinazolines have reached the marked. Herein we report on a new scaffold, 5-aryl-7H-pyrrolo[2,3-d]pyrimidin-4-amines, and show that when employing (S)-phenylglycinol as C-4 substituent, potent inhibitors can be made. The two most active inhibitors have suitable druglike properties, were equipotent with Erlotinib in Ba/F3 cell studies, and showed lower cross reactivity than Erlotinib in a panel of 50 kinases.
We also recommend Trading Suppliers and Manufacturers of 4-(2-PHENYLETHYL)ANILINE (cas 13024-49-2). Pls Click Website Link as below: cas 13024-49-2 suppliers
Prev:Preliminary NotePhotochemical cyclization of polyfluorinated aryloxo-1,2-dihydronaphthalenes and 6-phenyl-3-phenoxy-2,4-cyclohexadienone
Next:Nucleophilic substitution of 4-bromomethyltriazolium with different nucleophiles) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Efficient synthesis of 3-substituted indoles through a domino gold(I) chloride catalyzed cycloisomerization/C3-functionalization of 2-(alkynyl)anilines09/02/2019
- Side-chain reactions in π-chromium tricarbonyl complexed arenes : II. Elimination from (2-phenylethyl tosylate)- and (2-phenylethyl bromide)-chromium tricarn the reaction with ethanolic sodium ethoxide09/01/2019
- Palladium catalysts immobilized in thin films of ionic liquid for the direct addition of aniline to styrene08/31/2019
- Direct asymmetric aldol reactions catalysed by trans-4-hydroxy-(S)-prolinamide in solvent-free conditions08/30/2019
- Nucleophilic substitution of 4-bromomethyltriazolium with different nucleophiles08/29/2019
